Treatment Options That Reduce the Duration of Sickle Cell Vaso-Occlusive Crises: A Systematic Review
- PMID: 36176876
- PMCID: PMC9510888
- DOI: 10.7759/cureus.28337
Treatment Options That Reduce the Duration of Sickle Cell Vaso-Occlusive Crises: A Systematic Review
Abstract
Most patients with sickle cell disease (SCD) seek hospital care because of pain symptoms. While some patients opt to treat themselves at home, some prefer to seek treatment in a hospital setting. There are, however, some patients with more complicated effects of the disease who seek treatment so often that they have been termed "super-users." This paper seeks to determine, across the board, the treatments available for vaso-occlusive crisis (VOC), the most common complication of SCD. Due to the frequency and unpredictable nature of VOC, it is no surprise that the lives of so many patients dealing with SCD are constantly disrupted by this complication. Treatments that reduce the frequency of VOC and the need for hospital admissions will help these patients find some semblance of balance in their quality of life.
Keywords: adult sickle cell anemia; haemostasis sickle cell anaemia; painful crisis; psychosocial issues sickle cell anaemia; sickle cell children; sickle cell crisis; sickle cell disease (scd); sickle cell trait; vaso occlusive crisis; vaso-occlusive pain.
Copyright © 2022, Akindele et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
A systematic literature review of frequency of vaso-occlusive crises in sickle cell disease.Orphanet J Rare Dis. 2021 Nov 2;16(1):460. doi: 10.1186/s13023-021-02096-6. Orphanet J Rare Dis. 2021. PMID: 34727959 Free PMC article.
-
Magnetic Resonance Imaging Assessment of Kidney Oxygenation and Perfusion During Sickle Cell Vaso-occlusive Crises.Am J Kidney Dis. 2017 Jan;69(1):51-59. doi: 10.1053/j.ajkd.2016.07.027. Epub 2016 Sep 20. Am J Kidney Dis. 2017. PMID: 27663041
-
Systematic Review of Crizanlizumab: A New Parenteral Option to Reduce Vaso-occlusive Pain Crises in Patients with Sickle Cell Disease.Pharmacotherapy. 2020 Jun;40(6):535-543. doi: 10.1002/phar.2409. Epub 2020 May 20. Pharmacotherapy. 2020. PMID: 32350885
-
Validation of patient-reported vaso-occlusive crisis day as an endpoint in sickle cell disease studies.Eur J Haematol. 2022 Sep;109(3):226-237. doi: 10.1111/ejh.13790. Epub 2022 Jun 20. Eur J Haematol. 2022. PMID: 35569114 Free PMC article.
-
Opioid Use in Patients With Sickle Cell Disease During a Vaso-Occlusive Crisis: A Systematic Review.Cureus. 2022 Jan 21;14(1):e21473. doi: 10.7759/cureus.21473. eCollection 2022 Jan. Cureus. 2022. PMID: 35106256 Free PMC article. Review.
Cited by
-
Sickle cell disease and opioid overdose outcomes in the United States: a nationwide analysis.Ann Hematol. 2025 Mar;104(3):1551-1561. doi: 10.1007/s00277-025-06236-x. Epub 2025 Mar 10. Ann Hematol. 2025. PMID: 40063244 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources